Diagnos (TSXV:ADK) Other Stockholders Equity : C$-0.00 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Diagnos Other Stockholders Equity?

Diagnos's Other Stockholders Equity for the quarter that ended in Dec. 2024 was C$-0.00 Mil.

Diagnos's quarterly Other Stockholders Equity declined from Jun. 2024 (C$9.86 Mil) to Sep. 2024 (C$0.00 Mil) and declined from Sep. 2024 (C$0.00 Mil) to Dec. 2024 (C$-0.00 Mil).

Diagnos's annual Other Stockholders Equity increased from Mar. 2022 (C$-0.00 Mil) to Mar. 2023 (C$-0.00 Mil) and increased from Mar. 2023 (C$-0.00 Mil) to Mar. 2024 (C$-0.00 Mil).

Diagnos Other Stockholders Equity Historical Data

The historical data trend for Diagnos's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Other Stockholders Equity Chart

Diagnos Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Stockholders Equity

Get a 7-Day Free Trial

Diagnos Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Stockholders Equity	Get a 7-Day Free Trial															9.88	-	9.86	-	-

Diagnos Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Diagnos Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Diagnos's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

DGNOF:USA

Address

7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7

Website

https://www.diagnos.com

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.

Executives

Tristram Coffin	10% Security Holder
Marc-andré Massue	Senior Officer
Robert Dunn	Director
Francis Bellido	Director
Vincent Duhamel	Director
André Larente	Director, Senior Officer
Guillermo Moreno Robles	Senior Officer
Georges Hébert	Director
Gestion Maurice Pinsonnault Inc.	10% Security Holder

Diagnos Headlines

No Headlines